个人中心 - 老虎社区

TenFace

IP属地：上海

帖子 · 2帖子 · 2
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- TenFaceTenFace
  ·2023-02-01
  6
  AnPac Bio-Medical Science Shares Rise 12% After Investment Agreements
  By Chris Wack AnPac Bio-Medical Science Co. Ltd. shares were up 12% to $8.15 after the company said
  AnPac Bio-Medical Science Shares Rise 12% After Investment Agreements
  12 评论
  点赞
  分享
  举报
- TenFaceTenFace
  ·2022-10-29
  666
  AnPac Bio announces plan to implement ADS ratio change
  AnPac Bio (NASDAQ:ANPC) plans to change the ratio of the company’s American Depositary Shares to its
  AnPac Bio announces plan to implement ADS ratio change
  133 评论
  点赞
  分享
  举报
暂无粉丝

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

老虎社区侵权投诉指引

中国互联网举报中心·北京互联网举报中心

网络谣言曝光台·扫黄打非举报中心

网络110报警服务

© 2018-2024 老虎社区版权所有

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

qrcode

关注我们

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3460283921076064","uuid":"3460283921076064","gmtCreate":1497189900521,"gmtModify":1504149991828,"name":"TenFace","pinyin":"tenface","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/c5958f380d9ecdd022146bdfd7322181","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":15,"tweetSize":2,"questionSize":0,"limitLevel":900,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.02.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"上海","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":622317351,"gmtCreate":1675214171173,"gmtModify":1675215382085,"author":{"id":"3460283921076064","authorId":"3460283921076064","name":"TenFace","avatar":"https://static.laohu8.com/c5958f380d9ecdd022146bdfd7322181","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3460283921076064","authorIdStr":"3460283921076064"},"themes":[],"htmlText":"6","listText":"6","text":"6","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/622317351","repostId":"2306489680","repostType":2,"repost":{"id":"2306489680","kind":"highlight","pubTimestamp":1674668340,"share":"https://www.laohu8.com/m/news/2306489680?lang=&edition=full","pubTime":"2023-01-26 01:39","market":"us","language":"en","title":"AnPac Bio-Medical Science Shares Rise 12% After Investment Agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2306489680","media":"marketwatch","summary":"By Chris Wack AnPac Bio-Medical Science Co. Ltd. shares were up 12% to $8.15 after the company said ","content":"<html><body><div itemprop=\"articleBody\" role=\"document\"> <div> <div> <div aria-hidden=\"true\"></div> </div> </div> <p>By Chris Wack</p><pre></pre> <p>AnPac Bio-Medical Science Co. Ltd. shares were up 12% to $8.15 after the company said that in December and January, it signed definitive investment agreements with several third party investors.</p> <p>The company said investors agreed to buy 29.7 million newly issued Class A ordinary shares at 17.5 cents a share, for a total purchase price of $5.2 million.</p> <div> <p>The closing is expected to take place within 30 days after signing.</p> <p>Concurrently, for each Class A share purchased, the investors will receive two warrants, with each warrant to buy one Class A share at 21 cents a share. The warrants will be exercisable within two years from the date of issuance.</p> <p>AnPac Bio-Medical Science expects to use the proceeds for its business-to-business Asian food e-commerce and Asian food supply chain construction.</p><pre></pre> <p>Write to Chris Wack at chris.wack@wsj.com</p><pre></pre> </div> </div></body></html>","source":"mwatch_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AnPac Bio-Medical Science Shares Rise 12% After Investment Agreements</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAnPac Bio-Medical Science Shares Rise 12% After Investment Agreements\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-01-26 01:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/anpac-bio-medical-science-shares-rise-12-after-investment-agreements-271674668375?mod=newsviewer_click><strong>marketwatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>By Chris Wack AnPac Bio-Medical Science Co. Ltd. shares were up 12% to $8.15 after the company said that in December and January, it signed definitive investment agreements with several third party ...</p>\n\n<a href=\"https://www.marketwatch.com/story/anpac-bio-medical-science-shares-rise-12-after-investment-agreements-271674668375?mod=newsviewer_click\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://images.barrons.com/im-709209?size=1.777777777777778&width=220 220w,https://images.barrons.com/im-709209?size=1.777777777777778&width=300 300w,https://images.barrons.com/im-709209?size=1.777777777777778&width=460 460w,https://images.barrons.com/im-709209?size=1.777777777777778&width=800 800w,https://images.barrons.com/im-709209?size=1.777777777777778&width=920 920w,https://images.barrons.com/im-709209?size=1.777777777777778&width=1240 1240w,https://images.barrons.com/im-709209?size=1.777777777777778&width=1240 1240w","relate_stocks":{"BK4139":"生物科技"},"source_url":"https://www.marketwatch.com/story/anpac-bio-medical-science-shares-rise-12-after-investment-agreements-271674668375?mod=newsviewer_click","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2306489680","content_text":"By Chris Wack AnPac Bio-Medical Science Co. Ltd. shares were up 12% to $8.15 after the company said that in December and January, it signed definitive investment agreements with several third party investors. The company said investors agreed to buy 29.7 million newly issued Class A ordinary shares at 17.5 cents a share, for a total purchase price of $5.2 million.  The closing is expected to take place within 30 days after signing. Concurrently, for each Class A share purchased, the investors will receive two warrants, with each warrant to buy one Class A share at 21 cents a share. The warrants will be exercisable within two years from the date of issuance. AnPac Bio-Medical Science expects to use the proceeds for its business-to-business Asian food e-commerce and Asian food supply chain construction. Write to Chris Wack at chris.wack@wsj.com","news_type":1},"isVote":1,"tweetType":1,"viewCount":12,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":665114119,"gmtCreate":1667031422731,"gmtModify":1667032961918,"author":{"id":"3460283921076064","authorId":"3460283921076064","name":"TenFace","avatar":"https://static.laohu8.com/c5958f380d9ecdd022146bdfd7322181","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3460283921076064","authorIdStr":"3460283921076064"},"themes":[],"htmlText":"666","listText":"666","text":"666","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/665114119","repostId":"2276419351","repostType":2,"repost":{"id":"2276419351","kind":"highlight","pubTimestamp":1666093817,"share":"https://www.laohu8.com/m/news/2276419351?lang=&edition=full","pubTime":"2022-10-18 19:50","market":"us","language":"en","title":"AnPac Bio announces plan to implement ADS ratio change","url":"https://stock-news.laohu8.com/highlight/detail?id=2276419351","media":"seekingalpha","summary":"AnPac Bio (NASDAQ:ANPC) plans to change the ratio of the company’s American Depositary Shares to its","content":"<html><body><ul>\n<li>AnPac Bio (<span>NASDAQ:ANPC</span>) plans to change the ratio of the company’s American Depositary Shares to its Class A ordinary shares from one ADS representing one Class A ordinary share to one  ADS representing twenty Class A ordinary shares.</li>\n<li>The change in the ADS ratio is expected to take place on November 4, 2022.</li>\n<li>For the company’s ADS holders, the change in the ADS ratio will have the same effect as a one-for-twenty reverse ADS split. </li>\n<li>The ADSs will continue to be traded on Nasdaq under the symbol “ANPC.”</li>\n<li>There will be no change to the company’s Class A ordinary shares.</li>\n<li>Shares are <font color=\"green\">up 1.7%</font> premarket.</li>\n</ul></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AnPac Bio announces plan to implement ADS ratio change</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAnPac Bio announces plan to implement ADS ratio change\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-10-18 19:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3892141-anpac-bio-announces-plan-to-implement-ads-ratio-change><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AnPac Bio (NASDAQ:ANPC) plans to change the ratio of the company’s American Depositary Shares to its Class A ordinary shares from one ADS representing one Class A ordinary share to one  ADS ...</p>\n\n<a href=\"https://seekingalpha.com/news/3892141-anpac-bio-announces-plan-to-implement-ads-ratio-change\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TQQQ":"纳指三倍做多ETF",".IXIC":"NASDAQ Composite","QLD":"纳指两倍做多ETF","SQQQ":"纳指三倍做空ETF","QQQ":"纳指100ETF","QID":"纳指两倍做空ETF","BK4139":"生物科技","PSQ":"纳指反向ETF"},"source_url":"https://seekingalpha.com/news/3892141-anpac-bio-announces-plan-to-implement-ads-ratio-change","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2276419351","content_text":"AnPac Bio (NASDAQ:ANPC) plans to change the ratio of the company’s American Depositary Shares to its Class A ordinary shares from one ADS representing one Class A ordinary share to one  ADS representing twenty Class A ordinary shares.\nThe change in the ADS ratio is expected to take place on November 4, 2022.\nFor the company’s ADS holders, the change in the ADS ratio will have the same effect as a one-for-twenty reverse ADS split. \nThe ADSs will continue to be traded on Nasdaq under the symbol “ANPC.”\nThere will be no change to the company’s Class A ordinary shares.\nShares are up 1.7% premarket.","news_type":1},"isVote":1,"tweetType":1,"viewCount":133,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"followers","isTTM":false}